Author:
Terletskaia-Ladwig Elena,Enders Gisela,Schalasta Gunnar,Enders Martin
Abstract
Abstract
Background
Seasonal RSV infections occur every year and affect particularly children under six months of age. Passive immunoprophylaxis with monoclonal antibody Palivizumab is recommended in the period with high risk of RSV infection. This study aims to define the period for the southern part of Germany (Stuttgart area).
Methods
Epidemiological analysis of the RSV situation in southern Germany from 1996 to 2004 and comparison of results with literature was made. The respiratory tract specimens were sent in for the detection of RSV mainly by paediatric clinics. Detection of RSV was carried out mainly by real-time RT-PCR or by ELISA "Pathfinder". RSV outbreaks were depicted as an absolute number and as a percentage of RSV diagnoses in a month. Onsets, offsets, peaks, duration and severity of RSV seasons were defined and analysed.
Results
An early season with strong RSV activity (early-high phase) was followed by a weaker late season (late-low phase) in a regular biennial rhythm. However, onsets, offsets and durations of outbreaks varied significantly from year to year. RSV epidemics in southern Germany were found to oscillate in an antiphase with RSV epidemics in Finland and Sweden.
Conclusion
The long-term regular biennial rhythm allows predicting whether the next outbreak will be late or early and whether RSV activity will be strong or weak. Not foreseeable, however, is the precise time of increase and decrease of RSV activity. Moreover, the regular seasonal pattern may be disrupted by irregular outbreaks. Thus, activity of RSV has to be monitored every year to define the period with high risk of infection.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Liese JG, Grill E, Fischer B, Roeckl-Wiedmann I, Carr D, Belohradsky BH: Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr. 2003, 162: 230-6.
2. Roeckl-Wiedmann I, Liese JG, Grill E, Fischer B, Carr D, Belohradsky BH: Economic evaluation of possible prevention of RSV-related hospitalizations in premature infants in Germany. Eur J Pediatr. 2003, 162: 237-44.
3. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Prophylaxe von bedrohlichen RSV-Erkrankungen durch Palivizumab. [http://www.dgpi.de/home/frame.html]
4. Gilchrist S, Torok TJ, Gary HE, Alexander JP, Anderson LJ: National surveillance for respiratory syncytial virus, United States, 1985–1990. J Infect Dis. 1994, 170: 986-90.
5. Mullins JA, Lamonte AC, Bresee JS, Anderson LJ: Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J. 2003, 22: 857-62.
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献